BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1484381 N#Cc1ccc(C2CC2)c(C2=CNC(C(=O)N(C3CC3)[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)O2)c1 InChI=1S/C25H26N8O2/c26-11-16-1-6-21(17-2-3-17)22(9-16)23-12-28-24(35-23)25(34)33(18-4-5-18)20-10-19(31(13-20)15-27)14-32-8-7-29-30-32/h1,6-9,12,17-20,24,28H,2-5,10,13-14H2 BKNGBANCELXUPX-UHFFFAOYSA-N 716485 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(5-cyano-2-cyclopropylphenyl)-N-cyclopropyloxazole-2-carboxamide::US20250034122, Example 1 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 5.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716485&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680200 513836537 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484382 N#Cc1ccc(C2CC2)c(-c2nnc(C(=O)N(C3CC3)[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)o2)c1 InChI=1S/C24H23N9O2/c25-11-15-1-6-20(16-2-3-16)21(9-15)22-28-29-23(35-22)24(34)33(17-4-5-17)19-10-18(31(12-19)14-26)13-32-8-7-27-30-32/h1,6-9,16-19H,2-5,10,12-13H2 DBTKWEYVGLBADT-UHFFFAOYSA-N 716487 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(5-cyano-2-cyclopropylphenyl)-N-cyclopropyloxazole-2-carboxamide::US20250034122, Example 2 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 11.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716487&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909087 513836539 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484383 N#Cc1cccc(-c2cnc(C(=O)N[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)o2)c1 InChI=1S/C19H16N8O2/c20-8-13-2-1-3-14(6-13)17-9-22-19(29-17)18(28)24-15-7-16(26(10-15)12-21)11-27-5-4-23-25-27/h1-6,9,15-16H,7,10-11H2,(H,24,28) GCDNSPSZRXTXAW-UHFFFAOYSA-N 716488 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-cyanophenyl)oxazole-2-carboxamide::US20250034122, Example 3 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 2.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716488&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909381 513836540 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484384 N#CN1C[C@H](NC(=O)c2ncc(-c3cccc(OC(F)(F)F)c3)o2)C[C@H]1Cn1ccnn1 InChI=1S/C19H16F3N7O3/c20-19(21,22)32-15-3-1-2-12(6-15)16-8-24-18(31-16)17(30)26-13-7-14(28(9-13)11-23)10-29-5-4-25-27-29/h1-6,8,13-14H,7,9-10H2,(H,26,30) CFWSXJDYVCYCSI-UHFFFAOYSA-N 716489 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-(trifluoromethoxy)phenyl)oxazole-2-carboxamide::US20250034122, Example 4 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 3.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716489&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909120 513836541 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484385 N#CN1C[C@H](NC(=O)c2ncc(-c3cccc(Cl)c3)o2)C[C@H]1Cn1ccnn1 InChI=1S/C18H16ClN7O2/c19-13-3-1-2-12(6-13)16-8-21-18(28-16)17(27)23-14-7-15(25(9-14)11-20)10-26-5-4-22-24-26/h1-6,8,14-15H,7,9-10H2,(H,23,27) HOWRICBKPZYKNY-UHFFFAOYSA-N 716490 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-chlorophenyl)oxazole-2-carboxamide::US20250034122, Example 5 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 4.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716490&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909236 513836542 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484386 COc1ccccc1-c1cnc(C(=O)N[C@@H]2C[C@@H](Cn3ccnn3)N(C#N)C2)o1 InChI=1S/C19H19N7O3/c1-28-16-5-3-2-4-15(16)17-9-21-19(29-17)18(27)23-13-8-14(25(10-13)12-20)11-26-7-6-22-24-26/h2-7,9,13-14H,8,10-11H2,1H3,(H,23,27) KZCVTPGHWRGGKC-UHFFFAOYSA-N 716491 US20250034122, Example 6 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 23.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716491&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909098 513836543 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484387 N#CN1C[C@H](NC(=O)c2nnc(-c3ccccc3C3CC3)o2)C[C@H]1Cn1ccnn1 InChI=1S/C20H20N8O2/c21-12-27-10-14(9-15(27)11-28-8-7-22-26-28)23-18(29)20-25-24-19(30-20)17-4-2-1-3-16(17)13-5-6-13/h1-4,7-8,13-15H,5-6,9-11H2,(H,23,29) JPWRARAGPYNONA-UHFFFAOYSA-N 716492 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropylphenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 7 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 35.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716492&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909391 513836544 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484388 N#CN1C[C@H](NC(=O)C2NC=C(c3ccccc3C3CC3)O2)C[C@H]1Cn1ccnn1 InChI=1S/C21H23N7O2/c22-13-27-11-15(9-16(27)12-28-8-7-24-26-28)25-20(29)21-23-10-19(30-21)18-4-2-1-3-17(18)14-5-6-14/h1-4,7-8,10,14-16,21,23H,5-6,9,11-12H2,(H,25,29) BFOKYTNUFJKCFU-UHFFFAOYSA-N 716493 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropylphenyl)oxazole-2-carboxamide::US20250034122, Example 8 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 14.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716493&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680202 513836545 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484389 N#Cc1ccc(C2CC2)c(C2=CNC(C(=O)N[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)O2)c1 InChI=1S/C22H22N8O2/c23-9-14-1-4-18(15-2-3-15)19(7-14)20-10-25-22(32-20)21(31)27-16-8-17(29(11-16)13-24)12-30-6-5-26-28-30/h1,4-7,10,15-17,22,25H,2-3,8,11-12H2,(H,27,31) CZCVKFVZUKRSBX-UHFFFAOYSA-N 716494 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(5-cyano-2-cyclopropylphenyl)oxazole-2-carboxamide::US20250034122, Example 9 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 2.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716494&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680203 513836546 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484390 N#CN1C[C@H](NC(=O)C2NC=C(c3ccccc3OC(F)(F)F)O2)C[C@H]1Cn1ccnn1 InChI=1S/C19H18F3N7O3/c20-19(21,22)32-15-4-2-1-3-14(15)16-8-24-18(31-16)17(30)26-12-7-13(28(9-12)11-23)10-29-6-5-25-27-29/h1-6,8,12-13,18,24H,7,9-10H2,(H,26,30) BXXIPTIPLBVDGQ-UHFFFAOYSA-N 716495 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-(trifluoromethoxy)phenyl)oxazole-2-carboxamide::US20250034122, Example 10 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 45.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716495&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680204 513836547 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484391 CCc1cccc(C2=CNC(C(=O)N[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)O2)c1 InChI=1S/C20H23N7O2/c1-2-14-4-3-5-15(8-14)18-10-22-20(29-18)19(28)24-16-9-17(26(11-16)13-21)12-27-7-6-23-25-27/h3-8,10,16-17,20,22H,2,9,11-12H2,1H3,(H,24,28) PAHSLMVWLXNFIN-UHFFFAOYSA-N 716496 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-ethylphenyl)oxazole-2-carboxamide::US20250034122, Example 11 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 4.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716496&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680205 513836548 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484392 N#CN1C[C@H](NC(=O)C2NC=C(c3cccc(C4CC4)c3)O2)C[C@H]1Cn1ccnn1 InChI=1S/C21H23N7O2/c22-13-27-11-17(9-18(27)12-28-7-6-24-26-28)25-20(29)21-23-10-19(30-21)16-3-1-2-15(8-16)14-4-5-14/h1-3,6-8,10,14,17-18,21,23H,4-5,9,11-12H2,(H,25,29) QRORVPGMFDPQNO-UHFFFAOYSA-N 716497 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-cyclopropylphenyl)oxazole2-carboxamide::US20250034122, Example 12 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 8.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716497&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680206 513836549 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484393 N#CN1C[C@H](NC(=O)C2NN=C(c3cc(OC(F)(F)F)ccc3C3CC3)O2)C[C@H]1Cn1ccnn1 InChI=1S/C21H21F3N8O3/c22-21(23,24)35-15-3-4-16(12-1-2-12)17(8-15)19-28-29-20(34-19)18(33)27-13-7-14(31(9-13)11-25)10-32-6-5-26-30-32/h3-6,8,12-14,20,29H,1-2,7,9-10H2,(H,27,33) KWXKHHCTMVWZSI-UHFFFAOYSA-N 716498 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropyl-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 13 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 5.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716498&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680207 513836550 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484394 N#Cc1ccc(C2CC2)c(C2=NNC(C(=O)N[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)O2)c1 InChI=1S/C21H21N9O2/c22-9-13-1-4-17(14-2-3-14)18(7-13)20-26-27-21(32-20)19(31)25-15-8-16(29(10-15)12-23)11-30-6-5-24-28-30/h1,4-7,14-16,21,27H,2-3,8,10-11H2,(H,25,31) PMICRXJLAHTUIO-UHFFFAOYSA-N 716499 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(5-cyano-2-cyclopropylphenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 14 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 4.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716499&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680208 513836551 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484395 N#CN1C[C@H](NC(=O)C2NN=C(c3cc(OC(F)(F)F)ccc3OC3CC3)O2)C[C@H]1Cn1ccnn1 InChI=1S/C21H21F3N8O4/c22-21(23,24)36-15-3-4-17(34-14-1-2-14)16(8-15)19-28-29-20(35-19)18(33)27-12-7-13(31(9-12)11-25)10-32-6-5-26-30-32/h3-6,8,12-14,20,29H,1-2,7,9-10H2,(H,27,33) IFXRLYNYRFBMMC-UHFFFAOYSA-N 716500 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropoxy-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 15 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 8.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716500&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680209 513836552 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484396 N#Cc1ccc(OC2COC2)c(C2=CNC(C(=O)N(C3CC3)[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)O2)c1 InChI=1S/C25H26N8O4/c26-9-16-1-4-22(36-20-13-35-14-20)21(7-16)23-10-28-24(37-23)25(34)33(17-2-3-17)19-8-18(31(11-19)15-27)12-32-6-5-29-30-32/h1,4-7,10,17-20,24,28H,2-3,8,11-14H2 YBFPJSSCMNFAOA-UHFFFAOYSA-N 716501 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(5-cyano-2-(oxetan-3-yloxy)phenyl)-N-cyclopropyloxazole-2-carboxamide::US20250034122, Example 16 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 28.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716501&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680210 513836553 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484397 N#Cc1cccc(C2=CNC(C(=O)N[C@@H]3C[C@@H](CN4N=CCN4)N(C#N)C3)O2)c1 InChI=1S/C19H20N8O2/c20-8-13-2-1-3-14(6-13)17-9-22-19(29-17)18(28)25-15-7-16(26(10-15)12-21)11-27-23-4-5-24-27/h1-4,6,9,15-16,19,22,24H,5,7,10-11H2,(H,25,28) NQFRWFNVDZRSHN-UHFFFAOYSA-N 716502 N-((3R,5S)-5-((2H-1,2,3-Triazol-2-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-cyanophenyl)oxazole-2-carboxamide::US20250034122, Example 17 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 4.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716502&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680211 513836554 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484398 N#Cc1cccc(C2=CNC(C(=O)N[C@@H]3C[C@@H](Cn4cncn4)N(C#N)C3)O2)c1 InChI=1S/C19H18N8O2/c20-6-13-2-1-3-14(4-13)17-7-23-19(29-17)18(28)25-15-5-16(26(8-15)10-21)9-27-12-22-11-24-27/h1-4,7,11-12,15-16,19,23H,5,8-9H2,(H,25,28) ZNEWRZFOOLMQPT-UHFFFAOYSA-N 716503 N-((3R,5S)-5-((1H-1,2,4-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-cyanophenyl)oxazole-2-carboxamide::US20250034122, Example 18 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 2.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716503&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680212 513836555 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484399 N#Cc1cccc(C2=CNC(C(=O)N[C@@H]3C[C@@H](CN4C=NNC4)N(C#N)C3)O2)c1 InChI=1S/C19H20N8O2/c20-6-13-2-1-3-14(4-13)17-7-22-19(29-17)18(28)25-15-5-16(27(8-15)10-21)9-26-11-23-24-12-26/h1-4,7,11,15-16,19,22,24H,5,8-9,12H2,(H,25,28) ZQDIYIGQOPITEC-UHFFFAOYSA-N 716504 N-((3R,5S)-5-((4H-1,2,4-Triazol-4-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-cyanophenyl)oxazole-2-carboxamide::US20250034122, Example 19 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 2.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716504&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680213 513836556 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484400 N#CN1C[C@H](NC(=O)c2cc(-c3cccc(C(F)(F)F)c3)ccn2)C[C@H]1Cn1ccnn1 InChI=1S/C21H18F3N7O/c22-21(23,24)16-3-1-2-14(8-16)15-4-5-26-19(9-15)20(32)28-17-10-18(30(11-17)13-25)12-31-7-6-27-29-31/h1-9,17-18H,10-12H2,(H,28,32) BFPQQRQUAKMYEI-UHFFFAOYSA-N 716505 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-4-(3-(trifluoromethyl)phenyl)picolinamide::US20250034122, Example 24 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 9.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716505&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909272 513836557 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484401 N#CN1C[C@H](NC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)ccn2)C[C@H]1Cn1ccnn1 InChI=1S/C21H18F3N7O2/c22-21(23,24)33-18-3-1-2-14(8-18)15-4-5-26-19(9-15)20(32)28-16-10-17(30(11-16)13-25)12-31-7-6-27-29-31/h1-9,16-17H,10-12H2,(H,28,32) AHRBNIXDBJQRKI-UHFFFAOYSA-N 716506 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-4-(3-(trifluoromethoxy)phenyl)picolinamide::US20250034122, Example 25 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 9.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716506&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909183 513836558 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484402 N#Cc1cccc(C2=CNC(C(=O)N[C@@H]3C[C@@H](Cn4cccn4)N(C#N)C3)O2)c1 InChI=1S/C20H19N7O2/c21-9-14-3-1-4-15(7-14)18-10-23-20(29-18)19(28)25-16-8-17(26(11-16)13-22)12-27-6-2-5-24-27/h1-7,10,16-17,20,23H,8,11-12H2,(H,25,28) HCDUGXLXPCMHDT-UHFFFAOYSA-N 716507 N-((3R,5S)-5-((1H-Pyrazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-cyanophenyl)oxazole-2-carboxamide::US20250034122, Example 26 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 5.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716507&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680214 513836559 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484403 N#CN1C[C@H](NC(=O)C2NC=C(c3cccc(OC(F)(F)F)c3)O2)C[C@H]1Cn1cccn1 InChI=1S/C20H19F3N6O3/c21-20(22,23)32-16-4-1-3-13(7-16)17-9-25-19(31-17)18(30)27-14-8-15(28(10-14)12-24)11-29-6-2-5-26-29/h1-7,9,14-15,19,25H,8,10-11H2,(H,27,30) HHQVBQAVKNEYCH-UHFFFAOYSA-N 716508 N-((3R,5S)-5-((1H-Pyrazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-(trifluoromethoxy)phenyl)oxazole-2-carboxamide::US20250034122, Example 27 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 9.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716508&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680215 513836560 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484404 Cc1ccn(C[C@@H]2C[C@@H](NC(=O)C3NC=C(c4cccc(OC(F)(F)F)c4)O3)CN2C#N)n1 InChI=1S/C21H21F3N6O3/c1-13-5-6-30(28-13)11-16-8-15(10-29(16)12-25)27-19(31)20-26-9-18(32-20)14-3-2-4-17(7-14)33-21(22,23)24/h2-7,9,15-16,20,26H,8,10-11H2,1H3,(H,27,31) JSFZMTZSHZQQSI-UHFFFAOYSA-N 716509 US20250034122, Example 28 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 10.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716509&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680216 513836561 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484405 Cc1ccnn1C[C@@H]1C[C@@H](NC(=O)C2NC=C(c3cccc(OC(F)(F)F)c3)O2)CN1C#N InChI=1S/C21H21F3N6O3/c1-13-5-6-27-30(13)11-16-8-15(10-29(16)12-25)28-19(31)20-26-9-18(32-20)14-3-2-4-17(7-14)33-21(22,23)24/h2-7,9,15-16,20,26H,8,10-11H2,1H3,(H,28,31) QUQMUDYMYAEHSB-UHFFFAOYSA-N 716510 US20250034122, Example 29 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 55.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716510&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680217 513836562 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484406 N#CN1C[C@H](NC(=O)C2NC(c3cccc(C(F)(F)F)c3)=CO2)C[C@H]1Cn1cccn1 InChI=1S/C20H19F3N6O2/c21-20(22,23)14-4-1-3-13(7-14)17-11-31-19(27-17)18(30)26-15-8-16(28(9-15)12-24)10-29-6-2-5-25-29/h1-7,11,15-16,19,27H,8-10H2,(H,26,30) URPXDUMQEXAWCA-UHFFFAOYSA-N 716511 N-((3R,5S)-5-((1H-Pyrazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)(3(trifluoromethyl)phenyl)oxazole-2-carboxamide::US20250034122, Example 30 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 11.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716511&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680218 513836563 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484407 Cn1ncc2c1=CCC(c1ccc(C(=O)N[C@@H]3C[C@@H](Cn4cccn4)N(C#N)C3)c(F)c1)C=2 InChI=1S/C24H24FN7O/c1-30-23-6-4-16(9-18(23)12-28-30)17-3-5-21(22(25)10-17)24(33)29-19-11-20(31(13-19)15-26)14-32-8-2-7-27-32/h2-3,5-10,12,16,19-20H,4,11,13-14H2,1H3,(H,29,33) PVDBMRIHRGEYBO-UHFFFAOYSA-N 716512 N-((3R,5S)-5-((1H-Pyrazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-2-fluoro-4-(1-methyl-1H-indazol-5-yl)benzamide::US20250034122, Example 34 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 44.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716512&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680219 513836564 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484408 Cn1ncc2c1=CCC(c1ccc(C(=O)N[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)c(F)c1)C=2 InChI=1S/C23H23FN8O/c1-30-22-5-3-15(8-17(22)11-27-30)16-2-4-20(21(24)9-16)23(33)28-18-10-19(31(12-18)14-25)13-32-7-6-26-29-32/h2,4-9,11,15,18-19H,3,10,12-13H2,1H3,(H,28,33) HGUWZINSKJDPMH-UHFFFAOYSA-N 716513 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-2-fluoro-4-(1-methyl-1H-indazol-5-yl)benzamide::US20250034122, Example 35 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 27.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716513&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680220 513836565 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484409 N#CN1C[C@H](CC(=O)N2CCC(c3cccc(OC(F)(F)F)c3)C2)C[C@H]1Cn1cccn1 InChI=1S/C22H24F3N5O2/c23-22(24,25)32-20-4-1-3-17(11-20)18-5-8-28(13-18)21(31)10-16-9-19(29(12-16)15-26)14-30-7-2-6-27-30/h1-4,6-7,11,16,18-19H,5,8-10,12-14H2 XOKJCUHAVRFSFR-UHFFFAOYSA-N 716514 N-((3R,5S)-5-((1H-Pyrazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-3-(3-(trifluoromethoxy)phenyl) pyrrolidine-1-carboxamide::US20250034122, Example 36 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 100.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716514&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680221 513836566 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484410 N#CN1C[C@H](NC(=O)N2CC[C@@H](c3cccc(OC(F)(F)F)c3)C2)C[C@H]1Cn1cccn1 InChI=1S/C21H23F3N6O2/c22-21(23,24)32-19-4-1-3-15(9-19)16-5-8-28(11-16)20(31)27-17-10-18(29(12-17)14-25)13-30-7-2-6-26-30/h1-4,6-7,9,16-18H,5,8,10-13H2,(H,27,31) SVJUEEJYUQQLMZ-UHFFFAOYSA-N 716515 US20250034122, Example 37 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 120 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716515&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909133 513836567 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484411 N#CN1C[C@H](NC(=O)N2CC[C@H](c3cccc(OC(F)(F)F)c3)C2)C[C@H]1Cn1cccn1 InChI=1S/C21H23F3N6O2/c22-21(23,24)32-19-4-1-3-15(9-19)16-5-8-28(11-16)20(31)27-17-10-18(29(12-17)14-25)13-30-7-2-6-26-30/h1-4,6-7,9,16-18H,5,8,10-13H2,(H,27,31) SVJUEEJYUQQLMZ-UHFFFAOYSA-N 716516 US20250034122, Example 38 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 210 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716516&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909363 513836568 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484412 N#CN1C[C@H](NC(=O)C2NC=C(c3ccc(F)c(OC(F)(F)F)c3)O2)C[C@H]1Cn1ccnn1 InChI=1S/C19H17F4N7O3/c20-14-2-1-11(5-15(14)33-19(21,22)23)16-7-25-18(32-16)17(31)27-12-6-13(29(8-12)10-24)9-30-4-3-26-28-30/h1-5,7,12-13,18,25H,6,8-9H2,(H,27,31) SZOVVSFZBODUCX-UHFFFAOYSA-N 716517 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(4-fluoro-3-(trifluoromethoxy)phenyl)oxazole-2-carboxamide::US20250034122, Example 39 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 8.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716517&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680222 513836569 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484413 N#CC1=CN=C(N2CCC2)C(C2=NNC(C(=O)N[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)O2)C1 InChI=1S/C20H23N11O2/c21-8-13-6-16(17(23-9-13)29-3-1-4-29)19-26-27-20(33-19)18(32)25-14-7-15(30(10-14)12-22)11-31-5-2-24-28-31/h2,5,9,14-16,20,27H,1,3-4,6-7,10-11H2,(H,25,32) XSFWSHJDNOWPAD-UHFFFAOYSA-N 716518 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-(azetidin-1-yl)-5-cyanopyridin-3-yl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 40 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 12.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716518&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680223 513836570 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484414 N#CC1=CN=C(N2CCCC2)C(C2=NNC(C(=O)N[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)O2)C1 InChI=1S/C21H25N11O2/c22-9-14-7-17(18(24-10-14)30-4-1-2-5-30)20-27-28-21(34-20)19(33)26-15-8-16(31(11-15)13-23)12-32-6-3-25-29-32/h3,6,10,15-17,21,28H,1-2,4-5,7-8,11-12H2,(H,26,33) ZYTORKXQNNAFDA-UHFFFAOYSA-N 716519 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(5-cyano-2-(pyrrolidin-1-yl)pyridin-3-yl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 41 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 9.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716519&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680224 513836571 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484415 N#CN1C[C@H](NC(=O)C2NN=C(c3cc(OC(F)(F)F)ccc3Cl)O2)C[C@H]1Cn1ccnn1 InChI=1S/C18H16ClF3N8O3/c19-14-2-1-12(33-18(20,21)22)6-13(14)16-26-27-17(32-16)15(31)25-10-5-11(29(7-10)9-23)8-30-4-3-24-28-30/h1-4,6,10-11,17,27H,5,7-8H2,(H,25,31) HKIBAAMHZUWZJR-UHFFFAOYSA-N 716520 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-chloro-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 42 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 6.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716520&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680225 513836572 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484416 N#CN1C[C@H](NC(=O)C2NN=C(c3cccc(OC(F)(F)F)c3)O2)C[C@H]1Cn1ccnn1 InChI=1S/C18H17F3N8O3/c19-18(20,21)32-14-3-1-2-11(6-14)16-25-26-17(31-16)15(30)24-12-7-13(28(8-12)10-22)9-29-5-4-23-27-29/h1-6,12-13,17,26H,7-9H2,(H,24,30) YZTIBJZIMJRXHG-UHFFFAOYSA-N 716521 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(3-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 43 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 12.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716521&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680226 513836573 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484417 N#CN1C[C@H](NC(=O)C2NN=C(c3cc(OC(F)(F)F)ccc3C3CC3)O2)C[C@H]1Cn1cccn1 InChI=1S/C22H22F3N7O3/c23-22(24,25)35-16-4-5-17(13-2-3-13)18(9-16)20-29-30-21(34-20)19(33)28-14-8-15(31(10-14)12-26)11-32-7-1-6-27-32/h1,4-7,9,13-15,21,30H,2-3,8,10-11H2,(H,28,33) ZFPCPNQDPHFOEN-UHFFFAOYSA-N 716522 N-((3R,5S)-5-((1H-Pyrazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropyl-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 44 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 5.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716522&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680227 513836574 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484418 N#CN1C[C@H](NC(=O)C2NN=C(c3cc(OC(F)(F)F)ccc3C3CC3)O2)C[C@H]1CN1N=CCN1 InChI=1S/C21H23F3N8O3/c22-21(23,24)35-15-3-4-16(12-1-2-12)17(8-15)19-29-30-20(34-19)18(33)28-13-7-14(31(9-13)11-25)10-32-26-5-6-27-32/h3-5,8,12-14,20,27,30H,1-2,6-7,9-10H2,(H,28,33) MNNTZFJSAQOFDU-UHFFFAOYSA-N 716523 N-((3R,5S)-5-((2H-1,2,3-Triazol-2-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropyl-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 45 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 7.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716523&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680228 513836575 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484419 N#Cc1ccc(C2CC2)c(C2=NNC(C(=O)N[C@@H]3C[C@@H](Cn4cccn4)N(C#N)C3)O2)c1 InChI=1S/C22H22N8O2/c23-10-14-2-5-18(15-3-4-15)19(8-14)21-27-28-22(32-21)20(31)26-16-9-17(29(11-16)13-24)12-30-7-1-6-25-30/h1-2,5-8,15-17,22,28H,3-4,9,11-12H2,(H,26,31) DRMJQPWWLZETPR-UHFFFAOYSA-N 716524 N-((3R,5S)-5-((1H-Pyrazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(5-cyano-2-cyclopropylphenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 46 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 9.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716524&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680229 513836576 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484420 N#CN4C[C@H](NC(=O)C3NN=C(c1cc(OC(F)(F)F)ccc1C2CC2)O3)C[C@H]4Cn5cncn5 InChI=1S/C21H21F3N8O3/c22-21(23,24)35-15-3-4-16(12-1-2-12)17(6-15)19-29-30-20(34-19)18(33)28-13-5-14(31(7-13)9-25)8-32-11-26-10-27-32/h3-4,6,10-14,20,30H,1-2,5,7-8H2,(H,28,33) UOWGKUVCMCZOHJ-UHFFFAOYSA-N 716525 N-((3R,5S)-5-((1H-1,2,4-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropyl-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 47 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 5.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716525&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680230 513836577 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484421 CCCc1ccc(OC(F)(F)F)cc1C1=NNC(C(=O)N[C@@H]2C[C@@H](Cn3ccnn3)N(C#N)C2)O1 InChI=1S/C21H23F3N8O3/c1-2-3-13-4-5-16(35-21(22,23)24)9-17(13)19-28-29-20(34-19)18(33)27-14-8-15(31(10-14)12-25)11-32-7-6-26-30-32/h4-7,9,14-15,20,29H,2-3,8,10-11H2,1H3,(H,27,33) WJMZTYQIGLSORN-UHFFFAOYSA-N 716526 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-propyl-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 48 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 5.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716526&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680231 513836578 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484422 N#CN1C[C@H](NC(=O)C2NN=C(c3cc(OC(F)(F)F)ccc3C3CC3)O2)C[C@H]1CN1C=NNC1 InChI=1S/C21H23F3N8O3/c22-21(23,24)35-15-3-4-16(12-1-2-12)17(6-15)19-29-30-20(34-19)18(33)28-13-5-14(32(7-13)9-25)8-31-10-26-27-11-31/h3-4,6,10,12-14,20,27,30H,1-2,5,7-8,11H2,(H,28,33) HEHVGORZTUPXLL-UHFFFAOYSA-N 716527 N-((3R,5S)-5-((4H-1,2,4-Triazol-4-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropyl-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole-2-carboxamide::US20250034122, Example 49 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 6.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716527&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 175680232 513836579 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484423 N#CN1C[C@H](NC(=O)c2nc(-c3cc(OC(F)(F)F)ccc3C3CC3)no2)C[C@H]1Cn1ccnn1 InChI=1S/C21H19F3N8O3/c22-21(23,24)34-15-3-4-16(12-1-2-12)17(8-15)18-28-20(35-29-18)19(33)27-13-7-14(31(9-13)11-25)10-32-6-5-26-30-32/h3-6,8,12-14H,1-2,7,9-10H2,(H,27,33) JZAXONHFROFXGE-UHFFFAOYSA-N 716528 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-3-(2-cyclopropyl-5-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole-5-carboxamide::US20250034122, Example 50 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 5.00 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716528&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909377 513836580 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484424 N#CN1C[C@H](NC(=O)c2noc(-c3cc(OC(F)(F)F)ccc3C3CC3)n2)C[C@H]1Cn1ccnn1 InChI=1S/C21H19F3N8O3/c22-21(23,24)34-15-3-4-16(12-1-2-12)17(8-15)20-28-18(29-35-20)19(33)27-13-7-14(31(9-13)11-25)10-32-6-5-26-30-32/h3-6,8,12-14H,1-2,7,9-10H2,(H,27,33) FQUYGJYSTAONSP-UHFFFAOYSA-N 716529 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(2-cyclopropyl-5-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole-3-carboxamide::US20250034122, Example 51 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 14.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716529&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909190 513836581 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3 1484425 N#CN1C[C@H](NC(=O)c2ccc(-c3cccc4[nH]ncc34)nc2)C[C@H]1Cn1cccn1 InChI=1S/C22H20N8O/c23-14-29-12-16(9-17(29)13-30-8-2-7-26-30)27-22(31)15-5-6-20(24-10-15)18-3-1-4-21-19(18)11-25-28-21/h1-8,10-11,16-17H,9,12-13H2,(H,25,28)(H,27,31) BLRGJXLUAARVPL-UHFFFAOYSA-N 716530 N-((3R,5S)-5-((1H-Pyrazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-6-(1H-indazol-4-yl)nicotinamide::US20250034122, Example 52 Ubiquitin carboxyl-terminal hydrolase 30 Homo sapiens 15.0 US Patent 10.7270/Q2JM2G5K aid2060960 US20250034122 KEMP, MI; LUCKHURST, CA 1/30/2025 6/5/2025 Mission Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=716530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=708&target=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=716530&enzyme=Ubiquitin+carboxyl-terminal+hydrolase+30&column=ki&startPg=0&Increment=50&submit=Search 168909131 513836582 1 MLSSRAEAAMTAADRAIQRFLRTGAAVRYKVMKNWGVIGGIAAALAAGIYVIWGPITERKKRRKGLVPGLVNLGNTCFMNSLLQGLSACPAFIRWLEEFTSQYSRDQKEPPSHQYLSLTLLHLLKALSCQEVTDDEVLDASCLLDVLRMYRWQISSFEEQDAHELFHVITSSLEDERDRQPRVTHLFDVHSLEQQSEITPKQITCRTRGSPHPTSNHWKSQHPFHGRLTSNMVCKHCEHQSPVRFDTFDSLSLSIPAATWGHPLTLDHCLHHFISSESVRDVVCDNCTKIEAKGTLNGEKVEHQRTTFVKQLKLGKLPQCLCIHLQRLSWSSHGTPLKRHEHVQFNEFLMMDIYKYHLLGHKPSQHNPKLNKNPGPTLELQDGPGAPTPVLNQPGAPKTQIFMNGACSPSLLPTLSAPMPFPLPVVPDYSSSTYLFRLMAVVVHHGDMHSGHFVTYRRSPPSARNPLSTSNQWLWVSDDTVRKASLQEVLSSSAYLLFYERVLSRMQHQSQECKSEE 9F6G,9F19 Ubiquitin carboxyl-terminal hydrolase 30 UBP30_HUMAN Q70CQ3 Q8WTU7 Q96JX4 Q9BSS3 N/A A0A024RBM3